Status:

COMPLETED

Evaluation of Minimal Invasive Thyroidectomy

Lead Sponsor:

Kafrelsheikh University

Conditions:

Thyroid

Goiter

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

The goals of minimally invasive approaches are better cosmetic results with small neck scar, decreasing postoperative pain, and shortening of hospital stay periods without postoperative complications....

Detailed Description

Minimal invasive flapless thyroidectomy (MIFT) is a new technique that can be used in replacement of the conventional method of thyroidectomy for the management of selected cases of benign thyroid dis...

Eligibility Criteria

Inclusion

  • The limited size of the gland: volume less than 50 mm by ultrasound assessment. No evidence of retro-sternal extension. Benign nature of the disease proved by FNAC.

Exclusion

  • the patients who have one or more of the following criteria:
  • The size of the gland is more than 50 mm by ultrasound assessment.
  • Patients with retro-sternal goitre.
  • Patients with proved malignancy or suspicious for malignancy by Ultrasonography(US) or by Fine-Needle Aspiration Cytology (FNAC).
  • Previous surgery or radiotherapy to the neck.
  • Thyroiditis.

Key Trial Info

Start Date :

March 1 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 10 2022

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT05434715

Start Date

March 1 2021

End Date

June 10 2022

Last Update

June 28 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kafrelsheikh University

Kafr ash Shaykh, Kafr el-Sheikh Governorate, Egypt, 33516